期刊文献+

壳聚糖作为辅助成分在骨组织工程研究中的应用 被引量:1

暂未订购
导出
摘要 壳聚糖具有良好的生物相容性、生物可降解性、抗菌性等,可作为药物载体、支架等应用于生物组织工程。壳聚糖溶解性差、力学性能低、骨传导性缺乏等使其在骨组织工程中的广泛应用受到限制。将壳聚糖作为辅助成分与其他生物材料羟基磷灰石、磷酸三钙、聚甲基丙烯酸甲脂、聚乳酸-羟基乙酸共聚物等复合并协同作用,可达到取长补短的作用效果。该文就壳聚糖作为骨组织工程复合材料辅助成分的研究应用作一综述。
出处 《国际骨科学杂志》 2012年第6期395-397,共3页 International Journal of Orthopaedics
基金 上海市卫生局青年科研项目(2008Y069) 上海市科委医学引导类项目(09411962600)
  • 相关文献

参考文献31

  • 1de Souza R,Zahedi P, Allen CJ, et al. Hocompatibility of injectable chitosan-phospholipid inplant systems. Homaterials, 2009 , 30(23-24):3818-3824.
  • 2Ray SD. Potential aspects of chitosan as pharmaceutical exdpent. Acta PolPharm, 20U, 68(5) :619-622.
  • 3IXng SI. Preparation and properties of chitosan/ calcium phosphate corrjosites forbone repair. Dent Mater J, 2006, 25(4);706-712.
  • 4Jayakumar R, Prabaharan M,Nair SV,et al. Novel chi tin and chitosannanofibers in biomedical applications. Hotechnol Adv, 2010,28(1):142-150.
  • 5Costa-Rnto AR, Reis RL, Neves NM Scaffolds based bone tissue engineering:the role of chitosan. Tissue Ejig Part B Rev, 2011, 17(5) :331-347.
  • 6Khor E,Lim LY. Inplantable applications of chitin and chitosan. Homaterials,2003,24(13) :2339-2349.
  • 7Kumar MN, Muzzarelli RA, Muzzarelli C,et al. Chitosan chonistry andpharmaceutical perspectives. Chem Rev, 2004, 104(12) :6017-6084.
  • 8Shao HJ, Ho CC, Lee YT, et al. Chondrcenesis of human bone marrowmesenchymal cells by transforming growth factors (31 through cell shape changeson controlled biomaterials. J Homed Mater Res A, 2012,100(12); 3344-3352.
  • 9Fakhry A, Schndder GB, Zaharias R, et al. Qiitosan supports the initialattachment and spreading of osteoblasts preferentially over fibroblasts.Homaterials, 2004 , 25(11):2075-2079.
  • 10Nagahama H, Rani W, Shalumon KT,et al. Preparation, characterization,bioactive and cell attachment studies of alpha- chitin/ gelatin conpositemembranes, tit J Hoi Micromol, 2009 , 44(4) :333-337.

同被引文献50

  • 1王娅,冯扬,唐休发.纤维蛋白凝胶在组织工程中的应用[J].国际口腔医学杂志,2008,35(S1):31-33. 被引量:4
  • 2陈廖斌,汪晖,商亮.聚酸酐药物控释系统在骨科的研究与应用[J].临床外科杂志,2004,12(12):774-776. 被引量:1
  • 3陈发明,吴织芬,金岩.生长因子载体及缓释系统的研究进展[J].国外医学(口腔医学分册),2005,32(1):44-46. 被引量:8
  • 4李开南,刘建峰,汪学军,兰海,何智勇,熊成东,张明梅.可生物降解聚-DL-乳酸腰椎间融合器的设计及生物力学研究[J].中国脊柱脊髓杂志,2007,17(1):38-41. 被引量:7
  • 5Musgrave DS,Fu FH,Huard J.Gene therapy and tissue engineering in orthopaedic surgery.J Am Acad Orthop Surg. 2002;10(1 ):6-15.
  • 6Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: state of the art and future trends.Macromol Biosci. 2004; 4(8): 743-765.
  • 7Middleton JC,Tipton AJ.Synthetic biodegradable polymers as orthopedic devices. Biomaterials.2000;21 (23 ):2335-2346.
  • 8Nagahama H,Rani W,Shalumon KT, et al. Preparation, characterization, bioactive and cell attachment studies of alpha-chitin/gelatin composite menbranes.lnt J Bioi Macrornol, 2009;44(4 ):333-337.
  • 9Fakhry A,Schneider GB,Zaharias R,ct al.Chitosan supports the initial attachment and spreading of osteoblasts preferentially over fibroblasts. Biomaterials. 2004; 25(11): 2075-2079.
  • 10Kiang T,Wen J,Lim HW,Leong KW.The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials. 2004; 25( 5) :293-301 .

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部